Fate Therapeutics, Inc. News Headlines

FATE 
$7
*  
0.25
 negative 
3.45%
Get FATE Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Fate Reports In-Line Loss in Q4 - Analyst Blog
3/20/2014 2:28:01 PM - Zacks.com

Fate Therapeutics Q4 Loss Widens - Quick Facts
3/17/2014 5:12:00 PM - RTT News

Fate Therapeutics' Prohema in Phase II Study - Analyst Blog
3/13/2014 11:50:01 AM - Zacks.com

Fate Therapeutics Begins Phase 2 Study Of PROHEMA For Hematologic Malignancies
3/12/2014 7:23:00 AM - RTT News

Fate Therapeutics: DmPGE2 Improves Functional Properties Of T Cells
2/26/2014 7:16:00 AM - RTT News

2 Speculative Biotechs For The 'Shotgun Investor'
10/29/2013 11:12:00 AM - Seeking Alpha

Insiders Buy Shares at Fate Therapeutics and ChemoCentryx
10/8/2013 3:05:00 PM - Minyanville

Fate Therapeutics: You Need A Lot Of Faith Investing In This Public Offering
10/2/2013 12:54:00 PM - Seeking Alpha

Fate Therapeutics prices IPO at $6, at low end of the revised range
10/1/2013 8:38:04 AM - Renaissance Capital

Orphan disease biotech Fate Therapeutics decreases range and increases shares offered
9/30/2013 10:46:46 AM - Renaissance Capital

9 US IPOs planned for the week of Sep 30
9/30/2013 8:00:03 AM - Renaissance Capital

13 U.S. IPOs Planned For The Week Of September 23
9/24/2013 8:38:00 AM - Seeking Alpha

13 US IPOs planned for the week of Sep 23
9/23/2013 8:00:04 AM - Renaissance Capital

IPO Preview: Fate Therapeutics
9/18/2013 6:28:00 PM - Seeking Alpha

12 U.S. IPOs Planned For The Week Of September 16
9/16/2013 3:57:00 PM - Seeking Alpha

12 US IPOs planned for the week of Sep 16
9/16/2013 11:47:34 AM - Renaissance Capital

U.S. IPO Recap: Benefitfocus, Six Others Set Terms As Calendar Rebuilds
9/10/2013 8:21:00 AM - Seeking Alpha

Orphan disease biotech Fate Therapeutics sets terms for $60 million IPO
9/3/2013 8:46:29 AM - Renaissance Capital

U.S. IPO Recap: Regado Slashes Valuation, 3 Deals Added To IPO Pipeline
8/26/2013 2:56:00 PM - Seeking Alpha

U.S. IPO Recap: 2013 Breaks Past 2012's IPO Totals In Pricings And Filings
8/19/2013 1:47:00 PM - Seeking Alpha

Orphan disease biotech Fate Therapeutics files for a $69 million IPO
8/14/2013 9:01:32 AM - Renaissance Capital